Introduction to Genentech Legal Counsel and Vice President, 1976-1988, and Entrepreneur

Document Type

Introduction

Publication Date

2002

Abstract

I first met Tom Kiley at a deposition in San Francisco in 1981. Although I can't recall the witness, I remember the setting vividly. We were in a conference room in the law offices of Heller, Ehrman, White & McAuliffe, high above the ground in the heart of the financial district, facing north across the San Francisco Bay. It was a clear day, and it seemed that there were almost as many lawyers in the room as there were sailboats in the water. As a new associate in the firm, I had just been added to a growing litigation team at work on an interesting new case in the office involving rights in a cell line that had been used in the course of cloning an interferon gene. On one side of the dispute was our client, Hoffmann-La Roche, and its research partner, Genentech. On the other side was my alma mater, the University of California. Hoffmann-La Roche, having agreed to absorb the full cost of any potential damage award in order to remove a potential cloud on Genentech's initial public offering of stock, had assumed control of our side of the litigation.

eisenberg_genentech.pdf (126 kB)
PDF version of html work


Share

COinS